ClinicalTrials.Veeva

Menu

Hearables: Ear-ECG and PPG for Detection of Cardiac Arrhythmias

Imperial College London logo

Imperial College London

Status

Enrolling

Conditions

Arrhythmia

Treatments

Device: Ear ECG/PPG sensors

Study type

Observational

Funder types

Other

Identifiers

NCT06667258
22HH7866
318229 (Other Identifier)

Details and patient eligibility

About

The goal of this observational study is to determine the feasibility of detecting abnormal heart rhythms, known as arrhythmias, by recording Electrocardiogram (ECG) and Photoplethysmogram (PPG) waveforms from the ears in patients who have already been diagnosed with arrhythmias. The main questions it aims to answer are:

  • Can ECG and PPG signals from the ears reliably detect arrhythmias?
  • How do ear-based ECG/PPG waveforms compare to standard single-lead ECG in detecting abnormal rhythms?

Researchers will compare data from healthy controls and arrhythmia patients to see if ear-based recordings are as effective as traditional methods.

Full description

The main goal of this study is to determine the feasibility of detecting abnormal heart rhythms, known as arrhythmias, by recording Electrocardiogram (ECG) and Photoplethysmogram (PPG) waveforms from the ears.

The study includes both healthy control subjects and patients who have already been diagnosed with arrhythmias. These individuals will be approached by a clinical member of the research team during their hospital stay or outpatient visit at Imperial College NHS Trust (ICHNT). Patients will be given comprehensive information about the study through a patient information sheet and will be asked for their written informed consent, with adequate time provided for questions and understanding.

To capture Ear-ECG/PPG waveforms, a variety of standard medical-grade sensors and electrodes will be placed in and around both ears. These include standard EEG electrodes on each mastoid secured with medical-grade gel, and an in-ear foam-based earpiece (like commercial earplugs) with cloth electrodes. An additional PPG sensor (MAX30101 from Maxim Integrated) will be attached to the back of the ear with adhesive medical tape. The patient will also be connected to a standard single-lead ECG and a blood pressure cuff, already part of their standard care on the hospital ward.

Once the setup is complete, each patient will follow 3 different recording protocols displayed on a screen. Patients will be asked to sit upright (Protocol 1) and engage in a series of simple activities with designated breaks in between, including head movements, counting aloud to 60, chewing gum (or simulating chewing), walking (if able) freely under medical supervision with assistance if needed (Protocol 2), slow controlled breathing and immersing their hand in cold water (Protocol 3). The total recording time including setup will be approximately 20 minutes.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Able to give informed consent;
  • Healthy and diagnosed with cardiac arrhythmias.

Exclusion criteria

  • No abnormal ear anatomy

Trial design

100 participants in 2 patient groups

Healthy
Description:
Volunteers who have not been diagnosed with any heart rhythm problems, or patients whose heart rhythm issues are not showing up at the time of recruitment.
Treatment:
Device: Ear ECG/PPG sensors
Arrhythmia patients
Description:
Patients who have been previously diagnosed with an abnormal heart rhythm and are showing signs of it when they join the study.
Treatment:
Device: Ear ECG/PPG sensors

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Cheuk F. Wong; Patrik Bachtiger, MBBS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems